| human | Q5 |
| P6178 | Dimensions author ID | 01100243232.98 |
| P496 | ORCID iD | 0000-0002-8451-2817 |
| P108 | employer | Greenville Hospital System University Medical Center | Q5604698 |
| P734 | family name | Lessey | Q37487552 |
| Lessey | Q37487552 | ||
| Lessey | Q37487552 | ||
| P735 | given name | Bruce | Q579371 |
| Bruce | Q579371 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q99716050 | A Clinician's Guide to the Treatment of Endometriosis with Elagolix |
| Q33919012 | A balancing act: RNA binding protein HuR/TTP axis in endometriosis patients |
| Q44890841 | A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women |
| Q44327248 | A role for alphavbeta3 integrin during implantation in the rabbit model |
| Q30370823 | ARID1A Is Essential for Endometrial Function during Early Pregnancy |
| Q101569367 | ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation |
| Q112761159 | ARID1A and PGR proteins interact in the endometrium and reveal a positive correlation in endometriosis |
| Q35449469 | Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis |
| Q34683530 | Adhesion molecules and implantation |
| Q78353346 | Alterations in expression of endometrial endothelial nitric oxide synthase and alpha(v)beta(3) integrin in women with endometriosis |
| Q37924355 | Assessment of endometrial receptivity |
| Q50937282 | Assisted reproductive technology (ART) in the upstate: reducing the risks of multiple births. |
| Q54980466 | Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis. |
| Q37378434 | COUP-TFII regulates human endometrial stromal genes involved in inflammation. |
| Q33793529 | CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis |
| Q74676447 | Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening |
| Q24652129 | Characterization of antiestrogenic activity of the Chinese herb, prunella vulgaris, using in vitro and in vivo (Mouse Xenograft) models |
| Q34021048 | Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis |
| Q37967533 | Clinical assessment and management of the endometrium in recurrent early pregnancy loss |
| Q28364542 | Comparison of HSCORE assessment of endometrial beta3 integrin subunit expression with digital HSCORE using computerized image analysis (ImageJ) |
| Q28573581 | Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene |
| Q38881038 | Cytokine stimulation of MUC4 expression in human female reproductive tissue carcinoma cell lines and endometrial cancer |
| Q36204976 | DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination |
| Q35096893 | Decreased Notch pathway signaling in the endometrium of women with endometriosis impairs decidualization. |
| Q81390381 | Detecting differences in endometrial maturation? |
| Q49795189 | Detection of the smaller window of maximal receptivity: timing isn't everything |
| Q89660238 | Differential Expression of KRAS and SIRT1 in Ovarian Cancers with and Without Endometriosis |
| Q40278520 | ECC-1 cells: a well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium |
| Q40758221 | Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells |
| Q38601939 | Effect of randomized serum progesterone concentration on secretory endometrial histologic development and gene expression |
| Q50161431 | Effects of histone methyltransferase inhibition in endometriosis. |
| Q37118276 | Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women |
| Q40755740 | Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome |
| Q64886257 | Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis. |
| Q38862783 | Endometrial BCL6 Overexpression in Eutopic Endometrium of Women With Endometriosis |
| Q47220410 | Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes: a cohort study |
| Q36742625 | Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis |
| Q45326960 | Endometrial assessment: a clinical guide |
| Q33820399 | Endometrial beta3 integrin profile reflects endometrial receptivity defects in women with unexplained recurrent pregnancy loss |
| Q37311296 | Endometrial development and function in experimentally induced luteal phase deficiency |
| Q102321295 | Endometrial epithelial ARID1A is critical for uterine gland function in early pregnancy establishment |
| Q40113488 | Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium |
| Q33899735 | Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy |
| Q35755895 | Endometrial receptivity defects during IVF cycles with and without letrozole. |
| Q39365130 | Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why. |
| Q76379873 | Endometrial responsiveness to steroid hormones: a moving target |
| Q84144725 | Endometriosis and infertility |
| Q40062630 | Endometriosis markers: immunologic alterations as diagnostic indicators for endometriosis |
| Q96433272 | Establishment of an Immortalized Endometriotic Stromal Cell Line from Human Ovarian Endometrioma |
| Q35191246 | Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women |
| Q38085233 | Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects |
| Q90167824 | Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature |
| Q97077559 | Extracellular vesicles: a new understanding of endometrial receptivity? |
| Q60053984 | FOXO1 regulates uterine epithelial integrity and progesterone receptor expression critical for embryo implantation |
| Q43174603 | Fine tuning of endometrial function by estrogen and progesterone through microRNAs |
| Q36222589 | G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium |
| Q46212864 | Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis |
| Q27012789 | Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium |
| Q38222787 | Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone |
| Q37239796 | Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation |
| Q36031565 | IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors |
| Q47155750 | Immune-inflammation gene signatures in endometriosis patients |
| Q34597380 | Implantation defects in infertile women with endometriosis |
| Q40745247 | In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor |
| Q80196366 | Induction of trophinin in human endometrial surface epithelia by CGbeta and IL-1beta |
| Q34635268 | Integrins and implantation in the human |
| Q47144759 | Interleukin-33 modulates inflammation in endometriosis |
| Q89970957 | Interleukin-6 (IL-6) Activates the NOTCH1 Signaling Pathway Through E-Proteins in Endometriotic Lesions |
| Q36621649 | Intraoperative detection of subtle endometriosis: a novel paradigm for detection and treatment of pelvic pain associated with the loss of peritoneal integrity |
| Q36991826 | Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: a randomized clinical trial. |
| Q38654299 | KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance. |
| Q36767568 | Local and systemic factors and implantation: what is the evidence? |
| Q56609263 | Long-Term Outcomes of Elagolix in Women With Endometriosis |
| Q90969906 | Loss of HDAC3 results in nonreceptive endometrium and female infertility |
| Q112737541 | Loss of MIG-6 results in endometrial progesterone resistance via ERBB2 |
| Q39045047 | Luteal phase HCG support for unexplained recurrent pregnancy loss - a low hanging fruit? |
| Q49823118 | MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. |
| Q56001606 | MUC1 Is a Scaffold for Selectin Ligands in the Human Uterus |
| Q90898166 | Medical or surgical treatment before embryo transfer improves outcomes in women with abnormal endometrial BCL6 expression |
| Q37190151 | Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease |
| Q92499482 | Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model |
| Q96437102 | Non-bladder centric interstitial cystitis/bladder pain syndrome phenotype is significantly associated with co-occurring endometriosis |
| Q90020702 | Ovarian endometriosis and infertility: in vitro fertilization (IVF) or surgery as the first approach? |
| Q50910037 | Overexpression of Four Joint Box-1 Protein (FJX1) in Eutopic Endometrium From Women With Endometriosis. |
| Q84437703 | Plasma C3a-des-Arg levels in women with and without endometriosis |
| Q52581800 | Postmenopausal Deep Infiltrating Endometriosis of the Colon: Rare Location and Novel Medical Therapy. |
| Q45238677 | Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase |
| Q39251752 | Progesterone Resistance in Endometriosis Is Modulated by the Altered Expression of MicroRNA-29c and FKBP4. |
| Q37682116 | Progesterone function in human endometrium: clinical perspectives |
| Q35001895 | Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. |
| Q33914635 | Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility |
| Q51019563 | Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. |
| Q37268557 | Protein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis. |
| Q33518313 | Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis |
| Q33938559 | Proteomic analysis of the luteal endometrial secretome |
| Q35563944 | Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle |
| Q47292277 | RBPJ mediates uterine repair in the mouse and is reduced in women with recurrent pregnancy loss. |
| Q46594488 | Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q30835877 | Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation |
| Q44328851 | Regulated expression of osteopontin in the peri-implantation rabbit uterus |
| Q89597260 | Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis |
| Q57793556 | SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh |
| Q79330794 | Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinx increases the potential for spontaneous pregnancy |
| Q40561102 | Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial |
| Q44018218 | Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium |
| Q36853935 | Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients |
| Q44442564 | Temporal and morphologic characteristics of pinopod expression across the secretory phase of the endometrial cycle in normally cycling women with proven fertility |
| Q51771265 | The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial. |
| Q47387004 | The endometria of women with endometriosis exhibit dysfunctional expression of complement regulatory proteins during the mid secretory phase |
| Q35617070 | The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction |
| Q85710071 | The pathologists are free to go, or are they? |
| Q45059535 | Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist |
| Q35605011 | Two pathways of progesterone action in the human endometrium: implications for implantation and contraception |
| Q36981314 | Uterine receptivity: alterations associated with benign gynecological disease |
| Q92725520 | What exactly is endometrial receptivity? |
| Q33929428 | β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. |
Search more.